Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure

Circulation

Volumn 96, Issue 4, 1997, Pages 1173-1179

  Grassi, Guido ^a,b   Cattaneo, Bianca M ^b,c   Seravalle, Gino ^c   Lanfranchi, Antonio ^b   Pozzi, Massimo ^a   Morganti, Alberto ^b   Carugo, Stefano ^a   Mancia, Giuseppe ^a,b,c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

Author keywords

Angiotensin; Baroreceptors; Heart failure; Nervous system; Reflex; Renin

Indexed keywords

ANGIOTENSIN; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PLASMA RENIN ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC TONE;

EID: 0030760332     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.4.1173     Document Type: Article

References (51)

1. Chidsey CA, Harrison DC, Braunwald E. Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med. 1962;267:650-654.
2. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233-243.
3. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659-1666.
4. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nerve activity. Circulation. 1986;73:615-621.
5. Leimbach WN, Wallin GB, Victor RG, Aylward PE, Sundlöf G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913-919.
6. Gaffney TE, Braunwald E. Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am J Med. 1963;34:320-324.
7. Cohn JN, Levine B, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
8. Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J. 1987;114: 148-152.
9. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 1990;82:1730-1736.
10. Mancia G. Sympathetic activation in congestive heart failure. Eur Heart J. 1990;11(suppl A):3-11.
11. Packer M. Pathophysiology of chronic heart failure. Lancet. 1992; 340:88-95.
12. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
13. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
14. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327:685-691.
15. Pfeffer MA, Braunwald E, Moyè LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. for the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327:669-677.
16. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
17. Køber L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lynborg K, Videbaek J, Cole DS, Auclert L, Pauly NC, Aliot E, Persson S, Camm J, for the Trandolapril Cardiac Evaluation Study Group. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333: 1670-1676.
18. Gheorghiade M, Hall V, Lakier JB, Goldstein S. Comparative hemodynamic and ncurohumoral effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure. J Am Coll Cardiol. 1989;13:134-142.
19. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the Consensus Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 1990;82: 1730-1736.
20. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. for the V-HeFT VA Cooperative Studies Group. Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and effects of therapy in V-HeFT II. Circulation. 1993;87(suppl VI):VI-40-VI-48.
21. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalapril augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol. 1996;27:358-364.
22. Ferguson DW, Berg WJ, Roach PJ, Oren RM, Mark AL. Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol. 1991;69:523-531.
23. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:3206-3211.
24. Mancia G, Mark AL. Arterial baroreflex in humans. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology, Section 2: The Cardiovascular System. Bethesda, Md: American Physiological Society 1983:755-793.
25. Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 1989; 13:647-655.
26. Folland ED, Parisi AF, Moynihan PF, Jones DR, Feldman CL, Tow DE. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography: a comparison of cineangiographic and radionuclide techniques. Circulation. 1979;60: 760-766.
27. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity from peripheral nerves. Physiol Rev. 1979;59:919-957.
28. Hijemdal P, Daleskog M, Kanan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci. 1979;25:131-138.
29. Sealey JE, Laragh JH. How to do a plasma renin assay. Cardiovasc Med. 1977;2:1079-1092.
30. Morganti A, Grassi G, Giannattasio C, Bolla GB, Turolo L, Saino A, Sala C, Mancia G, Zanchetti A. Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension. J Hypertens. 1989;7:825-835.
31. Ludbrook J. On making multiple comparisons in clinical and experimental pharmacology and physiology. Clin Exp Pharmacol Physiol 1991;18:379-392.
32. Ferrario CM, Gildenber PL, McCubbin JW. Cardiovascular effects of angiotensin mediated by the central nervous system. Circ Res 1972;30:257-262.
33. Lewis GP, Reit E. The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J Physiol (Lond). 1965;179: 538-553.
34. Zimmerman BG. Actions of angiotensin on adrenergic nerve endings. Fed Proc. 1978;37:199-202.
35. Feldberg W, Lewis GP. The action of peptides on the adrenal medulla release of adrenaline by bradykinin and angiotensin. J Physiol (Lond). 1964;171:98-108.
36. Shimamoto K, Matsuki T, Iimura O. Angiotensin converting enzyme inhibitors and the kallikrein-kinin system. J Cardiovasc Pharmacol. 1995;15(suppl 6):S91-S98.
37. Giannattasio C, Failla M, Stella ML, Mangoni AA, Carugo S, Pozzi M, Grassi G, Mancia G. Alterations of radial artery compliance in patients with congestive heart failure. Am J Cardiol. 1995;76: 381-385.
38. Grassi G, Giannattasio C, Failla M, Pesenti A, Peretti G, Marinoni E, Fraschini N, Vailati S, Mancia G. Sympathetic modulation of radial artery compliance in congestive heart failure. Hypertension. 1995;26:348-354.
39. Giannattasio C, Failla M, Stella ML, Mangoni A, Turrini D, Carugo S, Pozzi M, Grassi G, Mancia G. Angiotensin converting enzyme inhibition and radial artery compliance in patients with congestive heart failure. Hypertension. 1995;26:491-496.
40. Guo GB, Abboud FM. Angiofensin II attenuates baroreflex control of heart rate and sympathetic activity. Am J Physiol. 1984;246: H80-H89.
41. Osterziel KJ, Röhrig N, Dietz R, Manthey J, Hecht J, Kühler W. Influence of captopril on the arterial baroreceptor reflex in patients with heart failure. Eur Heart J. 1988;9:1137-1145.
42. Osterziel KJ, Dietz R, Schmid W, Mikulaschek K, Manthey J, Kübler W. ACE-inhihition improves vagal reactivity in patients with heart failure. Am Heart J. 1990;120:1120-1129.
43. Mark AL, Mancia G. Cardiopulmonary baroreflexes in humans. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology. Section 2: The Cardiovascular System. Bethesda, Md: American Physiological Society; 1983:795-813.
44. Victor RG, Leinbach WN, Seals DR, Wallin BG, Mark AL. Effects of the cold pressor test on muscle sympathetic nerve activity in humans. Hypertension. 1987;9:429-436.
45. Seals DR, Victor RG, Mark AL. Plasma norepinephrine and muscle sympathetic discharge during rhythmic exercise in humans. J Appl Physiol. 1988;65:940-944.
46. Fagius J, Karhuvaara S. Sympathetic activity and blood pressure increases with bladder distension in humans. Hypertension. 1989;14: 511-517.
47. Mancia G, Grassi G, Parati G, Daffonchio A. Evaluating sympathetic activity in human hypertension. J Hypertens. 1993;11(suppl 5):SI3-S19.
48. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A, Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation. 1994;90:248-253.
49. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560-563.
50. Grassi G, Bolla GB, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci. 1997;92:285-289.
51. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recording. Circulation. 1989;80:65-77.